Dr. Todd E. Young, DO

Dr. Young practices at Texas Center for Urology in Fort Worth, Texas.

Dr. Young's NPI, 1568425064, was assigned on April 7, 2006. Dr. Young graduated from Texas College of Osteopathic Medicine in 1995. Dr. Young holds Texas license K2389.

Dr. Young's primary practice is Texas Center for Urology, at 2900 Acme Brick Plz, Fort Worth, TX 76109 in Tarrant County. The practice phone is (817) 871-9069.

Dr. Young's primary practice is Texas Center for Urology in Fort Worth, Texas. Dr. Young is also affiliated with Texas Health Fort Worth. The medical group on file is Texas Center for Urology. Dmand AI also links Dr. Young to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Young practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Young's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Young is board certified in 1997 - 2025 by the TX State License. Dr. Young is licensed in Texas.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery and kidney stone disease among the conditions Dr. Young treats.

CMS data shows 45,711 Medicare services from Dr. Young across 39 procedure codes in 2024, for 881 Medicare patients. Medicare paid $1,368,018 for them.

CMS counts 881 Medicare patients who saw Dr. Young in 2024. The largest group is 65 to 74, with 405 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Young's median patient age at 71, with 18% women.

In 2024, Dr. Young wrote 1,333 Medicare Part D claims for 449 patients. 91% of them were for generic drugs. CMS names the drug for 1,179 of them, across 17 drugs with 11 or more claims each, at $87,263 in total drug cost. In 2023, CMS named 859 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Young for performance year 2024, reported as part of a group. CMS counts 42 procedures of prostate resection by Dr. Young, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Young, published from 2003 to 2019. 2019 was the busiest year, with 2. The most frequent topics are Gene Expression, Monocytes and RNA, Messenger. Dr. Young has published most often in Proc Natl Acad Sci U S A. Dr. Young's most frequent co-authors are Eric S. Daar, MD, Marc Rosen, MD and Katya C. Corado, MD.

CMS Open Payments shows 777 general payments to Dr. Young from 75 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Coloplast Corp paid the most, $8,190.

Dmand AI lists 1 award for Dr. Young.

Dr. Young graduated from Texas College of Osteopathic Medicine in 1995. Dr. Young is a member of AOA.

Dr. Young is in network with 22 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.